Arsa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 4.00 M
- Satisfied Charges ₹ 4.00 M
About Arsa Pharmaceuticals
Arsa Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 1997 and has a history of 27 years and 11 months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Natarajan Conjeevaram, Sandhya Kosuri, and Kalpana Ramesh serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230TG1997PTC026635
-
Company No.
026635
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 1997
-
Date of AGM
29 Sep 2008
-
Date of Balance Sheet
31 Mar 2008
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Arsa Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Natarajan Conjeevaram
|
Managing Director | 12-Mar-1997 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sandhya Kosuri
|
Director | 12-Mar-1997 | Current |
|
Kalpana Ramesh
|
Director | 12-Mar-1997 | Current |
Financial Performance of Arsa Pharmaceuticals.
Enhance accessibility to Arsa Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arsa Pharmaceuticals?
Unlock access to Arsa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- Icici Bank Ltd. : 0.30 Cr
- Vijaya Bank : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2005 | Icici Bank Ltd. | ₹3.00 M | Open |
| 28 Feb 2004 | Vijaya Bank | ₹1.00 M | Open |
| 25 Feb 2005 | Andhra Pradesh State Financial Corporation | ₹3.00 M | Satisfied |
| 18 Dec 1999 | State Bank Of Hyderabad | ₹1.00 M | Satisfied |
How Many Employees Work at Arsa Pharmaceuticals?
Unlock and access historical data on people associated with Arsa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arsa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arsa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.